Some GLP-1s Achieve More Weight Loss Than Others

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.
Adverse events were frequent, and most were gastrointestinal-related, including nausea, vomiting, diarrhea, constipation.
LifeVantage's new MindBody GLP-1 System is riding the coattails of GLP-1 weight loss drugs. See why I rate LFVN stock as a ...
Dual- and triple-agonist GLP-1s appear to achieve greater weight loss in an overview of clinical trials of approved and ...
Weight management platform Found is today launching oral semaglutide dissolvable tablets for individuals looking for ...
Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...
Research showed that patients who lose weight on GLP-1 agonists frequently experience muscle mass loss. Obesity experts share ...